Wealth Plan Investment Management, LLC Crispr Therapeutics Ag Transaction History

Wealth Plan Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$51.17 - $68.18 $70,205 - $93,542	-1,372 Reduced 14.63%	8,009 $432,000
Q1 2024 May 16, 2024	SELL	$60.67 - $89.12 $17,108 - $25,131	-282 Reduced 2.92%	9,381 $639,000
Q4 2023 Jan 05, 2024	BUY	$38.62 - $72.18 $11,122 - $20,787	288 Added 3.07%	9,663 $604,000
Q3 2023 Nov 15, 2023	BUY	$45.39 - $59.0 $425,531 - $553,125	9,375 New	9,375 $425,000
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $28,646 - $44,660	659 Added 1136.21%	717 $40,000
Q2 2023 Jul 25, 2023	SELL	$43.47 - $67.77 $382,188 - $595,833	-8,792 Reduced 99.34%	58 $3,000
Q1 2023 May 08, 2023	BUY	$41.0 - $56.12 $53,341 - $73,012	1,301 Added 17.23%	8,850 $400,000
Q4 2022 Feb 15, 2023	BUY	$39.19 - $65.67 $4,271 - $7,158	109 Added 1.47%	7,549 $306,000
Q3 2022 Dec 12, 2022	SELL	$61.1 - $83.78 $15,824 - $21,699	-259 Reduced 3.36%	7,440 $377,000
Q1 2022 Sep 07, 2022	BUY	$53.19 - $79.24 $409,509 - $610,068	7,699 New	7,699 $382,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Wealth Plan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Plan Investment Management, LLC with notifications on news.